Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack has significant risks: 1 interaction(s) to avoid and 1 critical warning(s). Review carefully before proceeding.
1 combination(s) marked "avoid": CJC-1295 with DAC + Tesamorelin. Review these interactions carefully.

Cumulative Organ Load

GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (CJC-1295 with DAC, Tesamorelin). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (CJC-1295 with DAC, Tesamorelin). Monitor fasting glucose and HbA1c.
!
CJC-1295 with DAC + Tesamorelin
Avoid

Both are GHRH analogs; no additional benefit and potential receptor competition.

Researched 95% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.